BioCentury
ARTICLE | Company News

PBSC in expression profile deal with Xenometrix

November 14, 2000 8:00 AM UTC

Packard BioScience (PBSC) acquired a non-exclusive worldwide license to XENO's gene expression profiling technology, including biochips and high-density microarrays. PBSC will use the technology to ex...